Daily non-political popular news in brief.

Early promising results in malaria vaccine trial in Mali

A small clinical trial conducted by an international team of researchers in Mali has found that a candidate malaria vaccine was safe and elicited strong immune responses in the 40 Malian adults who received it. The trial was the first to test this vaccine candidate, which is designed to block the malaria parasite from entering human blood cells, in a malaria-endemic country.

Read more »

Keywords: promising, results, malaria, vaccine, trial, mali, result

« Previous | Next »

Similar news on "Early promising results in malaria vaccine trial in Mali":

1. Vaccine for brain tumors shows promising results
   11-16-2006 · EurekAlert!
   A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain, known as glioma, has shown promising results in preliminary data from a clinical trial at UCSF Medical Center.
   Similar news · Read more »
   
2. UCSF brain tumor vaccine trial shows promising results
   04-16-2007 · EurekAlert!
   A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain has shown promise in preliminary data from a clinical trial at the University of California, San Francisco.
   Similar news · Read more »
   
3. Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis
   10-03-2007 · EurekAlert!
   The first reported findings from an international, Phase 3 study showed that more than two-thirds of patients with moderate to severe plaque psoriasis receiving two doses of ustekinumab (CNTO 1275) achieved at least a 75 percent reduction in psoriasis at week 12, the primary endpoint of the study, as measured by the Psoriasis Area and Severity Index.
   Similar news · Read more »
   
4. Researchers complete first clinical trial of Apatone for cancer treatment
   10-05-2007 · EurekAlert!
   In a significant advancement in the ongoing battle against cancer, a group of researchers from Summa Health System, IC-MedTech and other institutions have completed the first ever FDA-approved human clinical trial of Apatone. Demonstrating promising results, Apatone exploits a new strategy to selectively lower the level of compounds within tumor cells that assist in energy production and protect against chemotherapy. This non-toxic approach weakens and kills cancers in a novel way.
   Similar news · Read more »
   
5. Anti-herpes treatment reduces HIV levels in women infected with both viruses
   02-21-2007 · EurekAlert!
   Experts call for HSV control measures, including vaccine, to rank high on international HIV prevention and research agenda as exciting trial findings are publishedTreating women who are infected with both the HSV-2 and HIV viruses with anti-herpes treatment can reduce the amount of HIV in the blood and genital secretions, according to the results of a trial published today in the New England Journal of Medicine.
   Similar news · Read more »
   
6. Human trial results show excellent safety data, from Geovax's DNA/MVA AIDS vaccines
   02-06-2007 · EurekAlert!
   GeoVax Labs, Inc. an Atlanta-based biotechnology company, today reported successful early results from two ongoing AIDS prevention Phase I human vaccine trials. Results from the first low-dose trial indicate a good safety profile as well as positive immune responses in human volunteers receiving 1/10th dose of GeoVax's AIDS vaccine. Results from a second larger full-dose trial also indicate a good safety profile in participants.
   Similar news · Read more »
   
7. Malaria: The right vaccine in the right place?
   03-12-2007 · EurekAlert!
   A new study on a malaria vaccine used at a testing site in Mali calls into question whether the best vaccine was chosen to be tested at this particular site.
   Similar news · Read more »
   
8. Promising results from first gene therapy clinical trial for Parkinson's disease reported
   06-21-2007 · EurekAlert!
   In what could be a breakthrough in the treatment of neurological disease, a team led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has completed the first-ever phase 1 clinical trial using gene therapy to battle Parkinson's disease.
   Similar news · Read more »
   
9. Preclinical results of Geovax's AIDS vaccines demonstrate potential to protect against disease
   02-06-2007 · EurekAlert!
   GeoVax Labs, Inc., an Atlanta-based biotechnology company, today reported successful results from a preclinical trial using GeoVax's vaccines for the therapeutic treatment and prevention of Acquired Immunodeficiency Disease Syndrome ("AIDS") in non-human primates. The data demonstrate the effectiveness of GeoVax's DNA/MVA vaccines in controlling the Simian ("SIV") AIDS virus through immune responses raised by the vaccines. These promising results have resulted in preliminary plans to conduct human therapeutic studies utilizing GeoVax's vaccines.
   Similar news · Read more »
   
10. Mayo Clinic reports possible new therapy for patients with platinum-resistant ovarian cancer
    10-23-2007 · EurekAlert!
    Mayo Clinic today reported promising interim results from a Phase II trial of a new combination therapy for patients with recurrent ovarian cancer that is resistant to platinum therapy.
    Similar news · Read more »